Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | leucine-rich repeat kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | leucine rich repeat serine:threonine protein | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Brugia malayi | Protein kinase domain containing protein | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Loa Loa (eye worm) | TKL/LRRK protein kinase | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Echinococcus multilocularis | leucine rich repeat serine:threonine protein | Get druggable targets OG5_131478 | All targets in OG5_131478 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | STE family protein kinase | 0.0063 | 0.2255 | 0.4991 |
Echinococcus multilocularis | myosin iiia | 0.0063 | 0.2255 | 0.2255 |
Echinococcus multilocularis | leucine rich repeat serine:threonine protein | 0.0071 | 0.2555 | 0.2555 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0124 | 0.4517 | 0.4517 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0124 | 0.4517 | 0.5886 |
Echinococcus granulosus | serine threonine protein kinase | 0.0124 | 0.4517 | 0.4517 |
Loa Loa (eye worm) | STE/STE20/MST protein kinase | 0.027 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0071 | 0.2555 | 0.2555 |
Plasmodium falciparum | protein kinase, putative | 0.0124 | 0.4517 | 1 |
Schistosoma mansoni | ste20-related kinase | 0.0208 | 0.7674 | 1 |
Loa Loa (eye worm) | TKL/LRRK protein kinase | 0.0071 | 0.2555 | 0.2555 |
Entamoeba histolytica | serine/threonine protein kinase STE20, putative | 0.0063 | 0.2255 | 0.4991 |
Plasmodium vivax | serine/threonine-specific protein kinase, putative | 0.0124 | 0.4517 | 1 |
Trypanosoma cruzi | STE/STE20 serine/threonine-protein kinase, putative | 0.0063 | 0.2255 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase 3 | 0.027 | 1 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0124 | 0.4517 | 1 |
Trypanosoma cruzi | STE/STE20 serine/threonine-protein kinase, putative | 0.0063 | 0.2255 | 1 |
Giardia lamblia | Kinase, STE STE20 | 0.0063 | 0.2255 | 0.5 |
Loa Loa (eye worm) | STE/STE20/YSK protein kinase | 0.0124 | 0.4517 | 0.4517 |
Entamoeba histolytica | serine/threonine-protein kinase 3, putative | 0.0063 | 0.2255 | 0.4991 |
Entamoeba histolytica | protein kinase, putative | 0.0124 | 0.4517 | 1 |
Onchocerca volvulus | Mitochondrial Rho GTPase homolog | 0.0003 | 0 | 0.5 |
Leishmania major | protein kinase, putative | 0.0063 | 0.2255 | 1 |
Echinococcus granulosus | serine:threonine protein kinase 3 | 0.027 | 1 | 1 |
Onchocerca volvulus | 0.0003 | 0 | 0.5 | |
Trypanosoma brucei | STE20-like serine/threonine-protein kinase 1, putative | 0.0063 | 0.2255 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0124 | 0.4517 | 1 |
Echinococcus granulosus | leucine rich repeat serine:threonine protein | 0.0072 | 0.2573 | 0.2573 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CL (ADMET) | = 48 ml/min.kg | Clearance in human liver microsomes | ChEMBL. | 25353650 |
IC50 (binding) | Inhibition of human recombinant MST2 using Ser/Thr peptide 7 substrate after 45 mins by Z-Lyte assay | ChEMBL. | 25353650 | |
IC50 (binding) | = 18 nM | Inhibition of GST-tagged truncated human recombinant LRRK2 using fluorescein-labeled LRRKtide peptide substrate incubated for 2 hrs | ChEMBL. | 25353650 |
IC50 (binding) | = 377 nM | Inhibition of full length LRRK2 (unknown origin) expressed in HEK293 cells assessed as reduction in S935 phosphorylation incubated for 90 mins by ELISA method | ChEMBL. | 25353650 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.